Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.
Clarivate Plc (NYSE: CLVT) is described as a leading global provider of transformative intelligence, with news that reflects its activities across Academia & Government, Intellectual Property and Life Sciences & Healthcare. Company announcements frequently highlight new AI-powered tools, analytical reports and customer adoptions that illustrate how Clarivate combines enriched data, analytics and workflow software.
Recent news includes the launch of the Web of Science Research Assistant, a generative AI-powered tool that helps researchers conduct natural-language searches, perform literature reviews and explore visualizations based on more than 120 years of publication and citation data. Clarivate also reports on studies such as the Pulse of the Library report, which surveys thousands of librarians worldwide about AI adoption, open science and budget pressures, and on the annual Highly Cited Researchers list, which recognizes researchers whose work has had broad influence based on Web of Science data.
In Intellectual Property, Clarivate issues updates on solutions like IPfolio and Derwent Patent Monitor, including customer selections by organizations such as Nissan Motor Co., Ltd. and FUJIFILM Holdings Corporation. These stories emphasize how IP management platforms and AI-enabled patent review tools support more efficient IP operations and collaboration between IP and R&D teams.
Life sciences and healthcare news often centers on Clarivate analyses such as the Drugs to Watch report and Companies to Watch reports, which identify emerging therapies and innovative companies using integrated, AI-enhanced datasets. Visitors to this news page can follow Clarivate’s product launches, research reports, customer case studies and investor-related announcements to understand how the company is applying data and AI across its core markets.
Clarivate Plc (NYSE: CLVT) announced that Executive Chairman Jerre Stead and CFO Richard Hanks will present at virtual investor conferences in November 2021. The first event is the RBC Capital Markets Global Technology Conference on November 17, 2021, at 9:35 AM ET, with a live webcast available for replay. The second event is the BofA Securities 2021 Leveraged Finance Conference on November 30, 2021, at 8:15 AM ET, also with a live webcast accessible for replay. For more details, visit clarivate.com.
Clarivate Plc (NYSE:CLVT) has been recognized by Forrester in their latest B2B2C Journey Mapping reports. These reports highlight the importance of transparency and trust in enhancing customer experiences. Clarivate's Customer Experience (CX) Services emphasizes the need for effective customer journey mapping, beginning with understanding customer feedback. The company also stresses the significance of recognizing partners' roles in customer experiences. This recognition underscores Clarivate's commitment to improving customer insights and driving business success.
Clarivate has partnered with the Biomedical Advanced Research and Development Authority (BARDA) to expedite the development of drug therapeutics that can serve as medical countermeasures (MCMs) for chlorine and sulfur mustard injuries. This collaboration will utilize machine learning and artificial intelligence to identify and repurpose existing FDA-approved drugs. Funding from BARDA will facilitate target identification and analyses, aiming to provide quicker responses to chemical exposure incidents. This initiative is part of BARDA's ReDIRECT program to enhance public health preparedness.
Summary not available.
On November 2, 2021, Clarivate Plc (NYSE: CLVT) announced a Virtual Investor Day scheduled for November 9, 2021. The event will provide updates on the company's business, with presentations from 10:00 AM to 1:00 PM Eastern Time. Participants can join via webcast through the Clarivate Investor Relations website. A replay will also be available afterwards. Clarivate aims to accelerate innovation through trusted information and insights, helping clients navigate complex challenges in science and intellectual property.
Clarivate Plc (NYSE:CLVT) has been selected by Hewlett Packard Enterprise (HPE) as its IP lifecycle management partner. This collaboration enables HPE to utilize Clarivate's IPfolio and Innography to streamline administrative processes and enhance innovation strategies. HPE will benefit from improved management of its extensive patent and trademark portfolio, enabling faster decision-making and better resource allocation. The integration of CompuMark’s trademark research into IPfolio allows for comprehensive trademark management, reinforcing HPE's objectives in innovation and business transformation.
Clarivate Plc (NYSE:CLVT) announced a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares. The dividend will be paid in cash on December 1, 2021 to shareholders of record by the close of business on November 15, 2021. This declaration reflects the company's commitment to returning value to its shareholders.
Clarivate Plc (NYSE: CLVT) announced an extension of its share repurchase program through January 31, 2022, allowing for up to $250 million in buybacks. As of the announcement, $185 million remains available from the initial authorization, which was set to expire on October 31, 2021. This move aims to enhance shareholder value and demonstrates the company’s commitment to returning capital to investors. The decision reflects positive management confidence in the company's financial position and future growth prospects.
Clarivate reported Q3 2021 results with revenues of $442.1 million, a 55% increase year-over-year. Adjusted revenues reached $442.2 million, up 54%. Net income improved to $0.9 million from a loss of $182 million in Q3 2020. Adjusted EBITDA rose 76% to $190 million. Notably, organic revenues increased 3%. The company maintains a strong outlook for Q4, projecting organic growth of 6%-8%. Additionally, a $250 million share repurchase program extension was approved, enhancing shareholder value.
Clarivate Plc (NYSE:CLVT) launched its Annual G20 Scorecard – Research Performance 2021 report, analyzing the research responses of G20 nations to COVID-19. The report reveals that nations with diverse research portfolios, like the US and Germany, are better equipped to address a wide array of COVID-19 challenges. Although Brazil shows strength in biosciences, others, like Mexico, experience declining research investment. The report highlights changes in research output and collaboration across nations, providing insights essential for policymakers and analysts ahead of the G20 Summit.
FAQ
What is the current stock price of Clarivate Plc (CLVT)?
What is the market cap of Clarivate Plc (CLVT)?
